Form 4: Oric Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Dominic Piscitelli, Chief Financial Officer of Oric Pharmaceuticals, Inc., sold 77,000 shares of common stock on August 26, 2026 for $13.69 per share.
Summary
- Option exercise/conversion: acquired 52,000 Common Stock at $4.36 ($226,720) on August 26, 2026; holds 121,828 after (Direct).
- Option exercise/conversion: acquired 25,000 Common Stock at $6.00 ($150,000) on August 26, 2026; holds 146,828 after (Direct).
- Open-market sale: disposed of 77,000 Common Stock at $13.69 ($1,053,814) on August 26, 2026; holds 69,828 after (Direct).
- Option exercise/conversion: disposed of 52,000 Stock Option (right to buy) on August 26, 2026; holds 92,500 after (Direct).
- Option exercise/conversion: disposed of 25,000 Stock Option (right to buy) on August 26, 2026; holds 120,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,053,814 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Dominic Piscitelli — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Option exercise/conversion | Common Stock | 52,000 | $4 | $226.7K | 121,828 |
| 2026-08-26 | Option exercise/conversion | Common Stock | 25,000 | $6 | $150.0K | 146,828 |
| 2026-08-26 | Open-market sale | Common Stock | 77,000 | $14 | $1.1M | 69,828 |
| 2026-08-26 | Option exercise/conversion | Stock Option (right to buy) | 52,000 | — | — | 92,500 |
| 2026-08-26 | Option exercise/conversion | Stock Option (right to buy) | 25,000 | — | — | 120,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Option exercise/conversion (52,000 shares) |
| 2026-08-26 | Option exercise/conversion (25,000 shares) |
| 2026-08-26 | Open-market sale (77,000 shares) |
| 2026-08-26 | Option exercise/conversion (52,000 shares) |
| 2026-08-26 | Option exercise/conversion (25,000 shares) |
Keywords
insider transaction, Form 4, ORIC, Oric Pharmaceuticals, Inc., bearish, Dominic Piscitelli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.